S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data
OncLive® On Air
00:00
Ivanesimab (AK-112) Structure and Action
John V. Heymach details ivanesimab's tetravalent design, daisy-chaining VEGF binding, and FC-null safety rationale.
Play episode from 09:08
Transcript
